GDRX GoodRx Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: GDRX

Price (delayed)

$7.1

Market cap

$2.8B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.02

Enterprise value

$2.84B

GoodRx Holdings, Inc. is a holding company that provides price comparison tool for prescriptions. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a number of different ...

Highlights
The company's EPS has shrunk by 167% QoQ but it has surged by 75% YoY
GoodRx Holdings's net income has shrunk by 159% QoQ but it has surged by 73% YoY
The quick ratio has decreased by 42% YoY and by 14% from the previous quarter
GoodRx Holdings's equity has decreased by 14% from the previous quarter and by 6% YoY
Sector: Healthcare
Industry: Health Information Services
Website: http://goodrx.com
Peers: PINS

Key stats

What are the main financial stats of GDRX
Market
Shares outstanding
395M
Market cap
$2.8B
Enterprise value
$2.84B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.78
Price to sales (P/S)
3.88
EV/EBIT
2,459.56
EV/EBITDA
25.18
EV/Sales
3.79
Earnings
Revenue
$750.27M
EBIT
$1.16M
EBITDA
$112.93M
Free cash flow
$82.53M
Per share
EPS
-$0.02
Free cash flow per share
$0.2
Book value per share
$1.88
Revenue per share
$1.83
TBVPS
$2.49
Balance sheet
Total assets
$1.59B
Total liabilities
$826.84M
Debt
$711.07M
Equity
$761.96M
Working capital
$750.23M
Liquidity
Debt to equity
0.93
Current ratio
7.12
Quick ratio
6.66
Net debt/EBITDA
0.34
Margins
EBITDA margin
15.1%
Gross margin
91.1%
Net margin
-1.2%
Operating margin
-3.6%
Efficiency
Return on assets
-0.5%
Return on equity
-1.1%
Return on invested capital
0.1%
Return on capital employed
0.1%
Return on sales
0.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GDRX stock price

How has the GoodRx Holdings stock price performed over time
Intraday
1.28%
1 week
-1.25%
1 month
5.65%
1 year
62.84%
YTD
5.97%
QTD
0%

Financial performance

How have GoodRx Holdings's revenue and profit performed over time
Revenue
$750.27M
Gross profit
$683.34M
Operating income
-$27.01M
Net income
-$8.87M
Gross margin
91.1%
Net margin
-1.2%
The net margin has plunged by 160% from the previous quarter but it has soared by 72% YoY
GoodRx Holdings's net income has shrunk by 159% QoQ but it has surged by 73% YoY
GDRX's gross profit is down by 2.6% year-on-year but it is up by 2.2% since the previous quarter
The revenue is down by 2.1% YoY

Growth

What is GoodRx Holdings's growth rate over time

Valuation

What is GoodRx Holdings stock price valuation
GDRX P/E details
P/E
N/A
P/B
3.78
P/S
3.88
EV/EBIT
2,459.56
EV/EBITDA
25.18
EV/Sales
3.79
The company's EPS has shrunk by 167% QoQ but it has surged by 75% YoY
GDRX's P/B is 30% above its last 4 quarters average of 2.9
GoodRx Holdings's equity has decreased by 14% from the previous quarter and by 6% YoY
The price to sales (P/S) is 18% higher than the last 4 quarters average of 3.3
The revenue is down by 2.1% YoY

Efficiency

How efficient is GoodRx Holdings business performance
The company's return on equity has shrunk by 161% QoQ but it has surged by 73% YoY
GoodRx Holdings's ROA has plunged by 156% from the previous quarter but it has soared by 76% YoY
The company's return on invested capital has shrunk by 95% QoQ and by 92% YoY
The company's return on sales has shrunk by 92% QoQ and by 86% YoY

Dividends

What is GDRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GDRX.

Financial health

How did GoodRx Holdings financials performed over time
GoodRx Holdings's total assets is 92% more than its total liabilities
The quick ratio has decreased by 42% YoY and by 14% from the previous quarter
The company's current ratio fell by 41% YoY and by 13% QoQ
The debt is 7% less than the equity
GDRX's debt to equity is up by 15% since the previous quarter and by 6% year-on-year
GoodRx Holdings's equity has decreased by 14% from the previous quarter and by 6% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.